Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1Phase 1 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2Tumor-Agnostic 1

Conditions

Breast Neoplasms 2Neoplasm Metastasis 1Depression 1

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Interventional × Psychotherapy, Group × Clear all
NCT06644170 2025-10-14

A Second Psilocybin Group Therapy for the Treatment of Cancer-Related Anxiety in Partial Responders With Metastatic Cancer

University of Washington

Phase 1 Completed
15 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT01727635 2012-11-16

The Long-term Effects of Body-mind-spirit Group Therapy

National Taiwan University Hospital

Phase 2/3 Completed
60 enrolled
Breast

Breast Neoplasms, Depression

NCT01108224 2010-04-21

Psychotherapy to Patients With Primary Breast Cancer - Psycho-social and Survival Outcome From a Randomised Trial

Danish Cancer Society

Phase NA Completed
210 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡